Effects of Oral and Transdermal Estrogen Replacement Therapy on Markers of Coagulation, Fibrinolysis, Inflammation and Serum Lipids and Lipoproteins in Postmenopausal Women
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Summary: We compared the effects of oral estradiol (2 mg), transdermal estradiol (50 g), and placebo on measures of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in 27 postmenopausal women at baseline and after 2 and 12 weeks of treatment. Oral and transdermal estradiol induced similar increases in serum free estradiol concentrations. Oral therapy increased the plasma concentrations of factor VII antigen (FVIIag) and activated factor VII (FVIIa), and the plasma concentration of the prothrombin activation marker prothrombin fragment 1+2 (F1+2). Oral but not transdermal estradiol therapy significantly lowered plasma plasminogen activator inhibitor-1 (PAI-1) antigen and tissue-type plasminogen activator (tPA) antigen concentrations and PAI-1 activity, and increased D-dimer concentrations, suggesting increased fibrinolysis. The concentration of soluble Eselectin decreased and serum C-reactive protein (CRP) increased significantly in the oral but not in the transdermal or placebo groups. In the oral but not in the transdermal or placebo estradiol groups low-density-lipoprotein (LDL) cholesterol, apolipoprotein B and lipoprotein (a) concentrations decreased while high-density-lipoprotein (HDL) cholesterol, apolipoprotein AI and apolipoprotein AII concentrations increased significantly. LDL particle size remained unchanged. In summary, oral estradiol increased markers of fibrinolytic activity, decreased serum soluble E-selectin levels and induced potentially antiatherogenic changes in lipids and lipoproteins. In contrast to these beneficial effects, oral estradiol changed markers of coagulation towards hypercoagulability, and increased serum CRP concentrations. Transdermal estradiol or placebo had no effects on any of these parameters. These data demonstrate that oral estradiol does not have uniformly beneficial effects on cardiovascular risk markers and that the oral route of estradiol administration rather than the circulating free estradiol concentration is critical for any changes to be observed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850 · cited 1×
“At concentrations below those of clinical inflammation, serum CRP concentrations have been associated with future coronary events in unstable angina (40) and in healthy postmenopausal women (41).”
BackgroundGerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens
Clauss, A. (1957) · Acta Haematologica · doi:10.1159/000205234 · Cited by 3,208
Grundy, S. M., Benjamin, I. J., Burke, G. L., Chait, A., Eckel, R. H., Howard, B. V., Mitch, W., Smith, S. C., & Sowers, J. R. (1999) · Circulation · doi:10.1161/01.cir.100.10.1134 · Cited by 2,698
Valery (1995) · doi:10.1001/jama.1995.03520270033028 · Cited by 2,320
Stampfer, M. J., & Colditz, G. A. (1991) · Preventive Medicine · doi:10.1016/0091-7435(91)90006-p · Cited by 1,600
Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease
Grodstein, F., Stampfer, M. J., Manson, J. E., Colditz, G. A., Willett, W. C., Rosner, B., Speizer, F. E., & Hennekens, C. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608153350701 · Cited by 1,305
DUNN, J. F., NISULA, B. C., & RODBARD, D. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-1-58 · Cited by 1,238
Walsh, B. W., Schiff, I., Rosner, B., Greenberg, L., Ravnikar, V., & Sacks, F. M. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110243251702 · Cited by 1,152
Nabulsi, A. A., Folsom, A. R., White, A., Patsch, W., Heiss, G., Wu, K. K., & Szklo, M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304153281501 · Cited by 906
Minimization: A new method of assigning patients to treatment and control groups
Taves, D. R. (1974) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1974155443 · Cited by 891
Europium as a label in time-resolved immunofluorometric assays
Hemmilä, I., Dakubu, S., Mukkala, V.-M., Siitari, H., & Lövgren, T. (1984) · Analytical Biochemistry · doi:10.1016/0003-2697(84)90095-2 · Cited by 833
Mosca, L., Manson, J. E., Sutherland, S. E., Langer, R. D., Manolio, T., & Barrett-Connor, E. (1997) · Circulation · doi:10.1161/01.cir.96.7.2468 · Cited by 736
Cushman, M., Legault, C., Barrett-Connor, E., Stefanick, M. L., Kessler, C., Judd, H. L., Sakkinen, P. A., & Tracy, R. P. (1999) · Circulation · doi:10.1161/01.cir.100.7.717 · Cited by 660 · cited 2×
“This finding is consistent with the PEPI-trial in which oral CEE combined with different progestins induced increases in serum CRP concentrations (7), and cross-sectional data showing unopposed estrogen users to have higher CRP concentrations compared to nonusers (6).”
ResultBiologic effects of transdermal estradiol
Chetkowski, R., Meldrum, D., & Steingold, K. (1987) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(87)90325-0 · Cited by 467
Repeated measurements and multiple comparisons in cardiovascular research
Ludbrook, J. (1994) · Cardiovascular Research · doi:10.1093/cvr/28.3.303 · Cited by 450
Heeschen, C., Hamm, C. W., Bruemmer, J., & Simoons, M. L. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00581-7 · Cited by 414
Effects of Hormone-Replacement Therapy on Fibrinolysis in Postmenopausal Women
Koh, K. K., Mincemoyer, R., Bui, M. N., Csako, G., Pucino, F., Guetta, V., Waclawiw, M., & Cannon, R. O. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703063361002 · Cited by 373
Jauhiainen, M., Koskinen, P., Ehnholm, C., Frick, M. H., Mänttäri, M., Manninen, V., & Huttunen, J. K. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90007-p · Cited by 354
Hormone replacement therapy and risk of venous thromboembolism: population based case-control study
Gutthann, S. P., Rodriguez, L. A. G., Castellsague, J., & Oliart, A. D. (1997) · BMJ · doi:10.1136/bmj.314.7083.796 · Cited by 338
Fluoroimmunoassays and immunofluorometric assays.
Hemmilä, I. (1985) · Clinical Chemistry · doi:10.1093/clinchem/31.3.359 · Cited by 303
Psaty, B. M. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.12.1333 · Cited by 301
Gebara, O. C. E., Mittleman, M. A., Sutherland, P., Lipinska, I., Matheney, T., Xu, P., Welty, F. K., Wilson, P. W. F., Levy, D., Muller, J. E., et al. (1995) · Circulation · doi:10.1161/01.cir.91.7.1952 · Cited by 298
A rapid micromethod for apolipoprotein E phenotyping directly in serum
Havekes, L. M., de Knijff, P., Beisiegel, U., Havinga, J., Smit, M., & Klasen, E. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38697-1 · Cited by 265
Koh, K. K., Cardillo, C., Bui, M. N., Hathaway, L., Csako, G., Waclawiw, M. A., Panza, J. A., & Cannon, R. O. (1999) · Circulation · doi:10.1161/01.cir.99.3.354 · Cited by 244
Hormone Replacement Therapy, Inflammation, and Hemostasis in Elderly Women
Cushman, M., Meilahn, E. N., Psaty, B. M., Kuller, L. H., Dobs, A. S., & Tracy, R. P. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.893 · Cited by 218
Coagulation Activation Following Estrogen Administration to Postmenopausal Women
Caine, Y. G., Bauer, K. A., Barzegar, S., ten Cate, H., Sacks, F. M., Walsh, B. W., Schiff, I., & Rosenberg, R. D. (1992) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646283 · Cited by 201
Sandberg, A. A., & Slaunwhite, W. R. (1957) · Journal of Clinical Investigation · doi:10.1172/jci103524 · Cited by 184 · cited 1×
“Serum estrone concentration increased more than 10-fold in the oral group, but remained unchanged in the transdermal group, reflecting differences in first-pass metabolism of these two estradiol preparations (23, 24).”
BackgroundTHE INTERCONVERSION OF ESTRONE AND ESTRADIOL BY HUMAN TISSUE SLICES1,2,3
RYAN, K. J., & ENGEL, L. L. (1953) · Endocrinology · doi:10.1210/endo-52-3-287 · Cited by 163
The Effects of Transdermal Estradiol and Oral Conjugated Estrogens on Haemostasis Variables
Kroon, U. ‐., Silfverstolpe, G., & Tengborn, L. (1994) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1642453 · Cited by 148
Postmenopausal Hormone Replacement Therapy Increases Coagulation Activity and Fibrinolysis
Teede, H. J., McGrath, B. P., Smolich, J. J., Malan, E., Kotsopoulos, D., Liang, Y.-L., & Peverill, R. E. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.5.1404 · Cited by 132
Kashyap, M. L., Hynd, B. A., & Robinson, K. (1980) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39803-5 · Cited by 127
Vehkavaara, S., Hakala-Ala-Pietilä, T., Virkamäki, A., Bergholm, R., Ehnholm, C., Hovatta, O., Taskinen, M.-R., & Yki-Järvinen, H. (2000) · Circulation · doi:10.1161/01.cir.102.22.2687 · Cited by 119
Self-citationCampagnoli, C., Biglia, N., Altare, F., Lanza, M. G., Lesca, L., Cantamessa, C., Peris, C., Fiorucci, G. C., & Sismondi, P. (1993) · Gynecological Endocrinology · doi:10.3109/09513599309152509 · Cited by 116
Granfone, A., Campos, H., McNamara, J. R., Schaefer, M. M., Lamon‐Fava, S., Ordovás, J. M., & Schaefer, E. J. (1992) · Metabolism · doi:10.1016/0026-0495(92)90008-x · Cited by 107
Blann, A. D., Amiral, J., & McCollum, C. N. (1997) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1997.tb00735.x · Cited by 89
Moorjani, S., Dupont, A., Labrie, F., Lignieres, B. D., Cusan, L., Dupont, P., Mailloux, J. R., & Lupien, P.-J. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-2-373 · Cited by 80
Davidson, M. H., Testolin, L. M., Maki, K. C., von Duvillard, S., & Drennan, K. B. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.11.1186 · Cited by 75
Relation of Hormone-Replacement Therapy to Measures of Plasma Fibrinolytic Activity
Shahar, E., Folsom, A. R., Salomaa, V. V., Stinson, V., McGovern, P. G., Shimakawa, T., Chambless, L. E., & Wu, K. K. (1996) · Circulation · doi:10.1161/01.cir.93.11.1970 · Cited by 67
Efficacy of transdermal estradiol
Judd, H. L. (1987) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(87)90172-4 · Cited by 63
Blann, A. D., Miller, J. P., & McCollum, C. N. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00081-6 · Cited by 54
Salomaa, V. V., Rasi, V., Pekkanen, J., Vahtera, E. M., Jauhiainen, M., Vartiainen, E. A., Ehnholm, C., Tuomilehto, J., & Myllylä, G. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.10.1549 · Cited by 52
Høibraaten, E., Os, I., Seljeflot, I., Andersen, T. O., Hofstad, A.-E., & Sandset, P. M. (2000) · Thrombosis Research · doi:10.1016/s0049-3848(99)00233-9 · Cited by 43
Heikkinen, A. M., NISKANEN, L. K., Ryynänen, M., Komulainen, M. H., Tuppurainen, M. T., Parviainen, M. T., & Saarikoski, S. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.2.402 · Cited by 41
Continuous, combined hormone replacement: randomized comparison of transdermal and oral preparations
Mattsson, L. (1999) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(99)00225-2 · Cited by 39
Lahdenperä, S., Puolakka, J. O., Pyorala, T., Luotola, H., & Taskinen, M. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05728-5 · Cited by 34
Self-citationWalsh, B. W., Spiegelman, D. L., Morrissey, M., & Sacks, F. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.3.5571 · Cited by 21
Cited by
Ding, E. L., Song, Y., Malik, V. S., & Liu, S. (2006) · JAMA · doi:10.1001/jama.295.11.1288 · Cited by 1,354
2016 IMS Recommendations on women’s midlife health and menopause hormone therapy
Baber, R. J., Panay, N., & Fenton, A. (2016) · Climacteric · doi:10.3109/13697137.2015.1129166 · Cited by 964
Treatment of symptoms of the menopause: an Endocrine Society Clinical Practice Guideline
Stuenkel, C. A., Davis, S. R., Gompel, A., Lumsden, M. A., Murad, M. H., Pinkerton, J. V., & Santen, R. J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2236 · Cited by 884
“The primary advantage of transdermal ET is to alleviate the firstpass hepatic metabolic effect (166) of oral estrogens resulting in a procoagulant effect and increases in SHBG, thyroid-binding globulin, cortisol-binding globulin (167, 168), triglycerides, and markers of inflammation such as C-reactive protein (167, 16…”
BackgroundPharmacology of estrogens and progestogens: influence of different routes of administration
Kuhl, H. (2005) · Climacteric · doi:10.1080/13697130500148875 · Cited by 835
Vascular Actions of Estrogens: Functional Implications
Miller, V. M., & Duckles, S. P. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.08002 · Cited by 593
Metadata
- Authors
- Vehkavaara, S., Silveira, A., Hakala-Ala-Pietilä, T., Virkamäki, A., Hovatta, O., Hamsten, A., Taskinen, M.-R., & Yki-Järvinen, H.
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 2001
- Volume
- 85
- Issue
- 04
- Pages
- 619-625
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W1841210688
- Cited by
- 270
- References
- 47
- FWCI
- 14.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.